Yonsei University College of Medicine-led research has shown amiloride is as effective as spironolactone in reducing systolic blood pressure (SBP) over 12 weeks in patients with resistant hypertension ...
Noninferiority trial favored amiloride as an alternative to spironolactone in lowering home systolic blood pressure (SBP) for people with resistant hypertension. Twelve weeks into the trial, mean home ...
Care for resistant hypertension is set to become more patient-centered. Credit: Brian A Jackson via Shutterstock. At the 2025 American Heart Association (AHA) Scientific Sessions held in New Orleans, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results